logo
Select company
Select metric
$ 4.88Operating Cash Flow per Share
VS
Market
76
Sector
92
Industry
98
History
100
$ 14.26Close
$ 8.21 - $ 14.6 52-Week Range
Ticker Information

Ticker

TBPH

Company Name

THERAVANCE BIOPHARMA INC

Sector

Healthcare

Industry

Biotechnology

Exchange

NASDAQ

THERAVANCE BIOPHARMA INC - Operating Cash Flow per Share Chart Analysis (TTM)

From
Zoom
1Y
3Y
5Y
10Y

TBPH - OCFPS Historical data
DateNet Cash Flow - OperationsOperating Cash Flow per ShareShare FactorWeighted Average Shares
6/30/2025$ 245.01M$ 4.88150.18M
3/31/2025$ 32.53M$ 0.65149.71M
12/31/2024$ -11.54M$ -0.24148.85M
9/30/2024$ -11.49M$ -0.23149.04M
6/30/2024$ -8.78M$ -0.18148.75M
3/31/2024$ -16.8M$ -0.35148.28M
12/31/2023$ -27M$ -0.49155.3M
9/30/2023$ -150.2M$ -2.87152.36M
6/30/2023$ -169.85M$ -3156.68M
3/31/2023$ -172.14M$ -2.74162.93M
Previous (option currently disabled)
1 (current)
Next (option currently disabled)

Key Performance Insights, Last 5 Years

  • THERAVANCE BIOPHARMA INC's latest trailing twelve months (TTM) OCFPS stands at $ -3.95.
  • Over the past 5 years, THERAVANCE BIOPHARMA INC's average OCFPS has been $ -1.73.
  • The median OCFPS for THERAVANCE BIOPHARMA INC during this period was $ -2.36
  • THERAVANCE BIOPHARMA INC reached its highest OCFPS over the past 5 years at $ 4.88.
  • The lowest OCFPS recorded by THERAVANCE BIOPHARMA INC in the same timeframe $ -4.11

THERAVANCE BIOPHARMA INC's OCFPS vs. competitors

We picked the following companies as peers based on multiple factors, including sector, industry, market capitalization and revenue

OCFPS Benchmarks
CompanyOCFPS
SAGE : SAGE THERAPEUTICS INC $ -4.62KURA : KURA ONCOLOGY INC $ 1.43ZVRA : ZEVRA THERAPEUTICS INC $ -0.84NKTR : NEKTAR THERAPEUTICS $ -13.13GYRE : GYRE THERAPEUTICS INC $ 0.01NRIX : NURIX THERAPEUTICS INC $ -2.74EYPT : EYEPOINT PHARMACEUTICALS INC $ -2.73SNDX : SYNDAX PHARMACEUTICALS INC $ -3.51ADCT : ADC THERAPEUTICS SA $ -1.12YMAB : Y-MABS THERAPEUTICS INC $ -0.39

Similar metrics to Shares WA:

Definition of Operating Cash Flow per Share

[Calculation] The amount of Operating Cash Flow attributed to each share, calculated as [NCFO] divided by the weighted average number of shares [SharesWA] after adjusting for [ShareFactor].
CF - Operations / (Shares WA * Share Factor)
(=) OCFPS OCFPS for THERAVANCE BIOPHARMA INC is calculated as follows: CF - Operations [ $ -249.83M ] / (Shares WA [ 63.3M ] * Share Factor [ 1 ])
(=) OCFPS [ $ -3.95 ]

TBPH - Operating Cash Flow per Share, Last 5 years

$ -4.11

Minimum

Mar 31, 2021

$ 4.88

Maximum

Jun 30, 2025

$ -1.73

Average

$ -2.36

Median

OCFPS Benchmark Analysis

 The chart above depicts the distribution of OCFPS for companies in the Total Stock Market. The average OCFPS of the companies is $ 1.65 with a standard deviation of $ 3.42.
The following table provides additional summary stats:
OCFPS in the Market:
filtered constituents3.79K
min$ -9.04
max$ 11.43
average$ 1.65
median$ 0.89
std$ 3.42